Drug Type CAR-T |
Synonyms mesoCAR, MesothelinCART |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 1 | China | 12 Jun 2017 |